Siemens to rebuild gamma cameras
The nuclear medicine group of Siemens Medical Systems in Hoffman Estates, IL, is giving a higher profile to its gamma camera remanufacturing capability. The company last month launched its Siemens Remanufactured Product (SRP) line, which it plans to
The nuclear medicine group of Siemens Medical Systems in Hoffman Estates, IL, is giving a higher profile to its gamma camera remanufacturing capability. The company last month launched its Siemens Remanufactured Product (SRP) line, which it plans to position as a viable alternative to new gamma cameras.
SRP cameras undergo a seven-step remanufacturing process, in which the systems are disassembled and rebuilt, with components repaired or replaced if necessary. The cameras are also refinished and include a one-year warranty, with a three-year warranty for crystals. Siemens claims that in some cases the systems emerge from the process better than when they were sold because they are brought up to current specifications, with state-of-the-art detectors, electronics, and other components.
In other Siemens nuclear medicine news, the company has released a new version of its ECAT ART positron emission tomography camera. Unveiled at the European Association of Nuclear Medicine meeting, the new ECAT ART features iterative reconstruction algorithms for better image quality and a single-photon scanning method that enables higher throughput for whole-body attenuation-corrected studies. Siemens first introduced ECAT ART at the 1994 Society of Nuclear Medicine meeting, and the camera carries a list price of $1.2 million (SCAN 6/15/94).
What is the Best Use of AI in CT Lung Cancer Screening?
April 18th 2025In comparison to radiologist assessment, the use of AI to pre-screen patients with low-dose CT lung cancer screening provided a 12 percent reduction in mean interpretation time with a slight increase in specificity and a slight decrease in the recall rate, according to new research.
The Reading Room: Racial and Ethnic Minorities, Cancer Screenings, and COVID-19
November 3rd 2020In this podcast episode, Dr. Shalom Kalnicki, from Montefiore and Albert Einstein College of Medicine, discusses the disparities minority patients face with cancer screenings and what can be done to increase access during the pandemic.
Can CT-Based AI Radiomics Enhance Prediction of Recurrence-Free Survival for Non-Metastatic ccRCC?
April 14th 2025In comparison to a model based on clinicopathological risk factors, a CT radiomics-based machine learning model offered greater than a 10 percent higher AUC for predicting five-year recurrence-free survival in patients with non-metastatic clear cell renal cell carcinoma (ccRCC).
Could Lymph Node Distribution Patterns on CT Improve Staging for Colon Cancer?
April 11th 2025For patients with microsatellite instability-high colon cancer, distribution-based clinical lymph node staging (dCN) with computed tomography (CT) offered nearly double the accuracy rate of clinical lymph node staging in a recent study.
